Lopes-Rodrigues et al. identified metabolic alterations in ABCB1-overexpressing cells, with EVs from MDR cells altering metabolic profiles in drug-sensitive cancer cells and thereby promoting MDR transfer[120]. This evidence concerns the gene ABCB1 and cancer.